Leveraging multimodal MRI-based radiomics analysis with diverse machine learning models to evaluate lymphovascular invasion in clinically node-negative breast cancer.
Heliyon. 2023 Dec 18;10(1):e23916. doi: 10.1016/j.heliyon.2023.e23916. eCollection 2024 Jan 15.
Heliyon. 2023.
PMID: 38192872
Free PMC article.